DE60318553D1 - USE OF A HSP-INDUCING COMPOUND TO LIMIT SECONDARY EFFECTS OF RETINOIDS - Google Patents

USE OF A HSP-INDUCING COMPOUND TO LIMIT SECONDARY EFFECTS OF RETINOIDS

Info

Publication number
DE60318553D1
DE60318553D1 DE60318553T DE60318553T DE60318553D1 DE 60318553 D1 DE60318553 D1 DE 60318553D1 DE 60318553 T DE60318553 T DE 60318553T DE 60318553 T DE60318553 T DE 60318553T DE 60318553 D1 DE60318553 D1 DE 60318553D1
Authority
DE
Germany
Prior art keywords
retinoids
hsp
inducing compound
secondary effects
limit secondary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60318553T
Other languages
German (de)
Other versions
DE60318553T2 (en
Inventor
Farra Claude Dal
Nouha Domloge
Dominique Peyronel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vincience SA
Original Assignee
Societe dExtraction des Principes Actifs SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0201539A external-priority patent/FR2835743B1/en
Priority claimed from FR0201746A external-priority patent/FR2835745B1/en
Application filed by Societe dExtraction des Principes Actifs SA filed Critical Societe dExtraction des Principes Actifs SA
Publication of DE60318553D1 publication Critical patent/DE60318553D1/en
Application granted granted Critical
Publication of DE60318553T2 publication Critical patent/DE60318553T2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to the use of an efficient quantity of at least a HSP inducing compound in or for the preparation of a composition, the compound or composition being intended to limit the side effects of retinoids. The present invention also relates to a cosmetic, pharmaceutical, or dermatological composition including, at least a retinoid and at least a HSP inducing compound, and its utilisation.
DE60318553T 2002-02-08 2003-02-05 USE OF A HSP-INDUCING COMPOUND TO LIMIT SECONDARY EFFECTS OF RETINOIDS Expired - Lifetime DE60318553T2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0201539A FR2835743B1 (en) 2002-02-08 2002-02-08 USE IN COSMETIC AND DERMATOLOGICAL COMPOSITIONS OF AN EXTRACT OF ARTEMIA IN COMBINATION WITH RETINOIDS
FR0201539 2002-02-08
FR0201746 2002-02-13
FR0201746A FR2835745B1 (en) 2002-02-13 2002-02-13 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING AN HSP INDUCER AND RETINOIDS, METHOD OF TREATMENT AND USE
PCT/FR2003/000359 WO2003066014A1 (en) 2002-02-08 2003-02-05 Use of a hsp inducing compound to limit secondary effects of retinoids

Publications (2)

Publication Number Publication Date
DE60318553D1 true DE60318553D1 (en) 2008-02-21
DE60318553T2 DE60318553T2 (en) 2009-02-05

Family

ID=27736154

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60318553T Expired - Lifetime DE60318553T2 (en) 2002-02-08 2003-02-05 USE OF A HSP-INDUCING COMPOUND TO LIMIT SECONDARY EFFECTS OF RETINOIDS

Country Status (6)

Country Link
US (1) US20050129779A1 (en)
EP (1) EP1480610B1 (en)
AT (1) ATE383145T1 (en)
AU (1) AU2003219269A1 (en)
DE (1) DE60318553T2 (en)
WO (1) WO2003066014A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858607B2 (en) * 2003-03-14 2010-12-28 Mamchur Stephen A System for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer
US20100129299A1 (en) * 2008-11-21 2010-05-27 Singleton Laura C Topical sunscreen compositions for mitigating effects on intracellular ion concentration
FR3006191B1 (en) * 2013-06-03 2016-04-29 Pierre Fabre Dermo-Cosmetique COSMETIC OR DERMATOLOGICAL COMPOSITIONS ASSOCIATED WITH RETINALDEHYDE AND GLYCYLGLYCINE OLEAMIDE, AND USES THEREOF IN COSMETICS OR DERMATOLOGY
FR3016126B1 (en) 2014-01-08 2017-06-23 Isp Investments Inc COSMETIC USE OF ARTEMIA SALINA EXTRACT TO PROTECT THE SKIN FROM THERMAL STRESS
CN105311636B (en) * 2015-11-18 2017-12-12 暨南大学 A kind of anti-herpesvirus ointment and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681784B1 (en) * 1991-10-01 1995-06-09 Fabre Pierre Cosmetique DERMATOLOGICAL AND / OR COSMETOLOGICAL COMPOSITION CONTAINING RETINOUIDES AND USE OF NEW RETINOUIDES.
IL121320A (en) * 1997-02-23 2000-12-06 Ibr Ltd Extracts from cells or tissue of organisms which are capable of entering dormancy for inhibition of proliferation of target cells or tissue
US5935596A (en) * 1997-03-20 1999-08-10 Chesebrough-Pond's Usa Co. Delivery of skin benefit agents via adhesive strips
DE19804837A1 (en) * 1998-01-29 1999-08-05 Coty Bv Cosmetic product for regeneration and stimulation of skin cells
US6274627B1 (en) * 1999-10-12 2001-08-14 Medinox, Inc. Conjugates of dithiocarbamate disulfides with pharmacologically active agents and uses therefor
FR2809308B1 (en) * 2000-05-29 2003-12-26 Seporga Lab COSMETIC OR DERMO-PHARMACEUTICAL PREPARATIONS CONTAINING HSP AND HSF FROM AN EXTRACT OF MUSHROOMS OR STRESSED YEAST
FR2810241B1 (en) * 2000-06-15 2003-10-17 Seporga Lab COSMETIC OR DERMO-PHARMACEUTICAL PREPARATIONS CONTAINING A ZOOPLANCTON EXTRACT WHICH CONTAINS AND INDUCES HSP

Also Published As

Publication number Publication date
ATE383145T1 (en) 2008-01-15
US20050129779A1 (en) 2005-06-16
AU2003219269A1 (en) 2003-09-02
EP1480610B1 (en) 2008-01-09
EP1480610A1 (en) 2004-12-01
DE60318553T2 (en) 2009-02-05
WO2003066014A1 (en) 2003-08-14

Similar Documents

Publication Publication Date Title
AR025247A1 (en) COMPOSITIONS OF STABLE CAROTENE-XANTOFIL GRANULES
AR047551A1 (en) ALUMINUM / ZIRCONIO / GLYCIN ANTRITRANSPIRANT ACTIVE COMPOUNDS, STABILIZED WITH BETAIN
DE60106954D1 (en) Resorcinol DERIVATIVES
PL365167A1 (en) Skin conditioning compositions containing compounds for mimicking the effect on skin of retinoic acid
ES2178298T3 (en) ANTI-INFLAMMATORY COMPOUNDS.
TR200100922T2 (en) Application of active substances through the lungs.
UY28348A1 (en) NEW COMPOUNDS
DE60302395D1 (en) System for distributing objects to multiple clients
BR9908020A (en) Optical polishing formula
BR0207775A (en) Amphoteric liposomes Methods for loading them with active ingredients and their use
ECSP045491A (en) NEW VENLAFAXINA O-DESMETIL FORMAMATE SALT
AR032287A1 (en) A COSMETIC COMPOSITION FOR SKIN CARE AND COSMETIC METHODS THAT USE THIS COMPOSITION
MX2009006216A (en) Emulsion comprising at least one retinoid and benzoyl peroxide.
PT1112266E (en) SUBSTITUTED 4-AMINO-2-ARYL-PYRIMIDINES, ITS PREPARATION, ITS USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
UY25712A1 (en) SUBSTITUTED BENZAMIDES AND THEIR APPLICATION IN MEDICINES
AR029590A1 (en) ANTIBACTERIALS
DE50213839D1 (en) THIN-LIQUID, SPRAYING W / O EMULSIONS
EP1576950A3 (en) Tapioca in cosmetic compositions
DE60101486D1 (en) Use of polyamino acid derivatives as a preservative
ATE383145T1 (en) USE OF A HSP-INDUCING COMPOUND TO LIMIT SECONDARY EFFECTS OF RETINOIDS
DOP2002000457A (en) TETRAHYDROQUINOLINS
BR0112537A (en) Cosmetic embellishment preparations containing dialkylcarbonates and metal oxides
ES2141978T3 (en) TRICYCLIC RETINOIDS, METHODS FOR THEIR PRODUCTION AND USE.
BR0307341A (en) Delta1-Pyrrolines
DE59808166D1 (en) USE OF 2-METHYL-THIAZOLIDINE-2,4-DICARBONIC ACID AS A MUCOLYTIC

Legal Events

Date Code Title Description
8364 No opposition during term of opposition